Journal of Virology

Journal

Publication Venue For

  • All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity of the Protein..  e0186522. 2023
  • HLA-II-Associated HIV-1 Adaptation Decreases CD4+ T-Cell Responses in HIV-1 Vaccine Recipients.  96. 2022
  • Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.  96. 2022
  • BK Polyomavirus Requires the Mismatch Repair Pathway for DNA Damage Response Activation.  96. 2022
  • Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.  96. 2022
  • Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.  96. 2022
  • Lentiviral Nef Proteins Differentially Govern the Establishment of Viral Latency.  96. 2022
  • Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4+ T Cell.  96. 2022
  • Host T Cell Dedifferentiation Effects Drive HIV-1 Latency Stability.  96. 2022
  • Human Cytomegalovirus Hijacks WD Repeat Domain 11 for Virion Assembly Compartment Formation and Virion Morphogenesis.  96. 2022
  • Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.  96. 2022
  • Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies.  96. 2022
  • Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.  96. 2022
  • A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.  95. 2021
  • Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.  95. 2021
  • Natural and recombinant SARS-CoV-2 isolates rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage.  95. 2021
  • A naturally occurring polymorphism in the base of Sudan virus glycoprotein decreases glycoprotein stability in a species-dependent manner.  95. 2021
  • A novel strain-specific neutralizing epitope on glycoprotein H of human cytomegalovirus.  95. 2021
  • Elevated HIV infection of CD4 T cells in MRKAd5 vaccine recipients due to CD8 T cells targeting adapted epitopes.  95. 2021
  • NAP1L1 and NAP1L4 binding to hypervariable domain of Chikungunya Virus nsP3 protein is bivalent and requires phosphorylation.  95. 2021
  • Adnaviria: A new realm for archaeal filamentous viruses with linear A-form double-stranded DNA genomes.  95. 2021
  • Link between interleukin-23 and anti-CD4 autoantibody production in antiretroviral-treated HIV-infected individuals.  95. 2021
  • Consequences of phosphorylation in a mononegavirales polymerase-cofactor system.  95. 2021
  • Generation and characterization of recombinant SARS-CoV-2 expressing reporter genes.  95. 2021
  • Localization of the WD repeat-containing protein 5 to the virion assembly compartment facilitates human cytomegalovirus assembly.  95. 2021
  • Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.  95. 2021
  • Dual pathways of human immunodeficiency virus type 1 envelope glycoprotein trafficking modulate the selective exclusion of uncleaved oligomers from virions.  95. 2021
  • Structure of nonstructural protein 1 from SARS-CoV-2.  95. 2021
  • Enterovirus infection induces massive recruitment of all isoforms of small cellular arf GTPases to the replication organelles.  95. 2021
  • Structural and functional characterization of host FHL1 Protein Interaction with Hypervariable Domain of Chikungunya Virus nsP3 Protein.  95. 2021
  • Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.  94. 2020
  • Cell fusion induced by a fusion-active form of human cytomegalovirus glycoprotein B (gB) is inhibited by antibodies directed at antigenic domain 5 in the ectodomain of gB.  94. 2020
  • Hypervariable domain of nsP3 of eastern equine encephalitis virus is a critical determinant of viral virulence.  94. 2020
  • Better viral control despite higher CD4+ T cell activation during acute HIV-1 infection in Zambian women is linked to the sex hormone estradiol.  94. 2020
  • BPIFB3 regulates endoplasmic reticulum morphology to facilitate flavivirus replication.  94. 2020
  • Long-Acting bms-378806 analogues stabilize the state-1 conformation of the human immunodeficiency virus type 1 envelope glycoproteins.  94. 2020
  • Mutations in hypervariable domain of venezuelan equine encephalitis virus nsP3 protein differentially affect viral replication.  94. 2020
  • Cross-reactive CD8 T-cell responses elicited by adenovirus type 5-based HIV-1 vaccines contributed to early viral evolution in vaccine recipients who became infected.  94. 2020
  • The connector domain of vesicular stomatitis virus large protein interacts with the viral phosphoprotein.  94. 2020
  • Primary HIV-1 strains use nef to downmodulate HLA-E surface expression.  93. 2019
  • The guanine nucleotide exchange factor GBF1 participates in rotavirus replication.  93. 2019
  • BK Polyomavirus Activates the DNA Damage Response to Prolong S Phase.  93. 2019
  • Novel mutations in NSP2 abolish Chikungunya virus-induced transcriptional shutoff and make the virus less cytopathic without affecting its replication rates.  93. 2019
  • A redundant mechanism of recruitment underlies the remarkable plasticity of the requirement of poliovirus replication for the cellular ArfGEF GBF1.  93. 2019
  • Defining HIV-1 envelope N-glycan microdomains through site-specific heterogeneity profiles.  93. 2019
  • Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice..  92. 2018
  • Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice..  92. 2018
  • Antisense-derived HIV-1 cryptic epitopes are not major drivers of viral evolution during the acute phase of infection.  92. 2018
  • Human cytomegalovirus immediate early 1 protein causes loss of SOX2 from neural progenitor cells by trapping unphosphorylated STAT3 in the nucleus.  92. 2018
  • Higher expectations for a vaccine to prevent congenital cytomegalovirus infection.  92. 2018
  • Multiple host factors interact with the hypervariable domain of chikungunya virus nsP3 and determine viral replication in cell-specific mode.  92. 2018
  • Incomplete downregulation of CD4 expression affects HIV-1 Env conformation and antibody-dependent cellular cytotoxicity responses..  92. 2018
  • WDR5 facilitates human cytomegalovirus replication by promoting capsid nuclear egress.  92. 2018
  • Novel insect-specific Eilat virus-based chimeric vaccine candidates provide durable, mono- and multivalent, single-dose protection against lethal alphavirus challenge.  92. 2018
  • β-D-N 4 -Hydroxycytidine is a potent anti-alphavirus compound that induces a high level of mutations in the viral genome.  92. 2018
  • Robust human and murine hepatocyte culture models of hepatitis B virus infection and replication.  92. 2018
  • Sindbis virus infection causes cell death by NSP2-induced transcriptional shutoff or by Nsp3-dependent translational shutoff.  92. 2018
  • Potent in vivo NK cellmediated elimination of HIV-1-infected cells mobilized by a gp120-bispecific and hexavalent broadly neutralizing fusion protein.  91. 2017
  • Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, noninfectious vaccine against Ebola virus challenge in mice.  91. 2017
  • Congenital human cytomegalovirus infection and the enigma of maternal immunity.  91. 2017
  • Attachment and postattachment receptors important for hepatitis C virus infection and cell-to-cell transmission.  91. 2017
  • Hypervariable domain of eastern equine encephalitis virus nsP3 redundantly utilizes multiple cellular proteins for replication complex assembly.  91. 2017
  • Glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers.  91. 2017
  • Tumor necrosis factor alpha-induced recruitment of inflammatory mononuclear cells leads to inflammation and altered brain development in murine cytomegalovirusinfected newborn mice.  91. 2017
  • TIM-1 promotes hepatitis C virus cell attachment and infection.  91. 2017
  • φX174 procapsid assembly: Effects of an inhibitory external scaffolding protein and resistant coat proteins in vitro.  91. 2017
  • Superior efficacy of a human immunodeficiency virus vaccine combined with antiretroviral prevention in simian-human immunodeficiency virus-challenged nonhuman primates.  90:5315-5328. 2016
  • BPIFB6 regulates secretory pathway trafficking and enterovirus replication.  90:5098-5107. 2016
  • Characterization of simian immunodeficiency virus variants anatomically compartmentalized in plasma and milk in chronically infected African green monkeys.  90:8795-8808. 2016
  • Correction: Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infection [Journal of Virology, 87, 20, (2013) (10968-10979)] doi: 10.1128/JVI.01120-13.  90:10431-10433. 2016
  • Dynamics and correlates of CD8 T-cell counts in Africans with primary human immunodeficiency virus type 1 infection.  90:10423-10430. 2016
  • Exploitation of interleukin-10 (IL-10) signaling pathways: Alternate roles of viral and cellular IL-10 in rhesus cytomegalovirus infection.  90:9920-9930. 2016
  • Structure and function of the N-terminal domain of the vesicular stomatitis virus RNA polymerase.  90:715-724. 2016
  • The SD1 subdomain of venezuelan equine encephalitis virus capsid protein plays a critical role in nucleocapsid and particle assembly.  90:2008-2020. 2016
  • Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines..  89:2301-2312. 2015
  • A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 Virus.  89:4655-4667. 2015
  • Association of HIV-1 envelope-specific breast milk IgA responses with reduced risk of postnatal mother-to-child transmission of HIV-1.  89:9952-9961. 2015
  • Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.  89:3846-3858. 2015
  • Comparative analysis of the glycosylation profiles of membrane-anchored HIV-1 envelope glycoprotein trimers and soluble gp140.  89:8245-8257. 2015
  • Emergence of highly pathogenic avian influenza A(H5N1) virus PB1-F2 variants and their virulence in BALB/c mice.  89:5835-5846. 2015
  • HIV-1 and morphine regulation of autophagy in microglia: Limited interactions in the context of HIV-1 infection and opioid abuse.  89:1024-1035. 2015
  • Human cytomegalovirus infection dysregulates the localization and stability of NICD1 and Jag1 in neural progenitor cells.  89:6792-6804. 2015
  • Identification of a neutralizing epitope within Antigenic domain 5 of glycoprotein B of human cytomegalovirus.  89:361-372. 2015
  • In vivo activation of human NK cells by treatment with an interleukin-15 superagonist potently inhibits acute in vivo HIV-1 infection in humanized mice.  89:6264-6274. 2015
  • MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a.  89:1070-1082. 2015
  • Stable phenotypic changes of the host T cells are essential to the long-term stability of latent HIV-1 infection.  89:6656-6672. 2015
  • The acetyltransferase Tip60 is a critical regulator of the differentiation-dependent amplification of human papillomaviruses.  89:4668-4675. 2015
  • The serum very-low-density lipoprotein serves as a restriction factor against hepatitis C virus infection.  89:6782-6791. 2015
  • The vaginal acquisition and dissemination of HIV-1 infection in a novel transgenic mouse model is facilitated by coinfection with herpes simplex virus 2 and is inhibited by microbicide treatment.  89:9559-9570. 2015
  • Vaccine-derived neutralizing antibodies to the human cytomegalovirus gH/gL pentamer potently block primary cytotrophoblast infection.  89:11884-11898. 2015
  • Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.  89:71-82. 2015
  • Global panel of HIV-1 env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies.  88:2489-2507. 2014
  • High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.  88:2025-2034. 2014
  • Interferon-stimulated poly(ADP-ribose) polymerases are potent inhibitors of cellular translation and virus replication.  88:2116-2130. 2014
  • Common mechanism for RNA encapsidation by negative-strand RNA viruses.  88:3766-3775. 2014
  • Enhanced viral replication and modulated innate immune responses in infant airway epithelium following H1N1 infection.  88:7412-7425. 2014
  • HIV-1 envelope glycan moieties modulate HIV-1 transmission.  88:14258-14267. 2014
  • Higher-order structure of the rous sarcoma virus SP assembly domain.  88:5617-5629. 2014
  • Identification of nucleotide-level changes impacting gene content and genome evolution in orthopoxviruses.  88:13651-13668. 2014
  • Immune activation is associated with CD8 T cell interleukin-21 production in HIV-1-infected individuals.  88:10259-10263. 2014
  • Influenza virus infectivity and virulence following ocular-only aerosol inoculation of ferrets.  88:9647-9654. 2014
  • Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.  88:364-376. 2014
  • Rewiring of cellular membrane homeostasis by picornaviruses.  88:9478-9489. 2014
  • The 5' untranslated region of the human T-cell lymphotropic virus type 1 mRNA enables cap-independent translation initiation.  88:5936-5955. 2014
  • Vaginal myeloid dendritic cells transmit founder HIV-1.  88:7683-7688. 2014
  • Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.  87:13480-13489. 2013
  • Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaques.  87:10447-10459. 2013
  • Vaccination against a virus-encoded cytokine significantly restricts viral challenge.  87:11323-11331. 2013
  • N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses.  87:8756-8766. 2013
  • Thiouracil cross-linking mass spectrometry: A cell-based method to identify host factors involved in viral amplification.  87:8697-8712. 2013
  • Comparison of the levels of infectious virus in respirable aerosols exhaled by ferrets infected with influenza viruses exhibiting diverse transmissibility phenotypes.  87:7864-7873. 2013
  • Hypervariable domain of nonstructural protein nsp3 of venezuelan equine encephalitis virus determines cell-specific mode of virus replication.  87:7569-7584. 2013
  • Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees.  87:7828-7836. 2013
  • Structural and functional characterization of the mumps virus phosphoprotein.  87:7558-7568. 2013
  • Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine.  87:6127-6136. 2013
  • Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes.  87:6866-6875. 2013
  • HIV-specific CD8+ T cells from elite controllers are primed for survival.  87:5170-5181. 2013
  • Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis.  87:5746-5754. 2013
  • HLA-B*57 versus HLA-B*81 in HIV-1 infection: Slow and steady wins the race?.  87:4043-4051. 2013
  • Venezuelan equine encephalitis virus nsP2 protein regulates packaging of the viral genome into infectious virions.  87:4202-4213. 2013
  • An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection.  87:2264-2277. 2013
  • Hypervariable Domains of nsP3 Proteins of New World and Old World Alphaviruses Mediate Formation of Distinct, Virus-Specific Protein Complexes.  87:1997-2010. 2013
  • Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection.  87:708-715. 2013
  • Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infection.  87:10968-10979. 2013
  • Mucosal tissue tropism and dissemination of HIV-1 subtype B acute envelope-expressing chimeric virus.  87:890-899. 2013
  • Pseudoinfectious Venezuelan Equine Encephalitis Virus: A New Means of Alphavirus Attenuation.  87:2023-2035. 2013
  • Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza a (H3N2v) virus in ferrets.  87:1261-1263. 2013
  • The amino-terminal domain of alphavirus capsid protein is dispensable for viral particle assembly but regulates RNA encapsidation through cooperative functions of its subdomains.  87:12003-12019. 2013
  • Tropism and infectivity of influenza virus, including highly pathogenic avian H5N1 virus, in ferret tracheal differentiated primary epithelial cell cultures.  87:2597-2607. 2013
  • Deletion of specific immune-modulatory genes from modified vaccinia virus ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques.  86:12605-12615. 2012
  • TLR7 Recognition is dispensable for influenza virus a infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice.  86:10988-10998. 2012
  • oral clarithromycin enhances airway immunoglobulin A (IgA) immunity through induction of IgA class switching recombination and B-cell-activating factor of the tumor necrosis factor family molecule on mucosal dendritic cells in mice infected with influenza a virus.  86:10924-10934. 2012
  • Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.  86:9055-9069. 2012
  • cell culture-adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious hepatitis C virus.  86:8987-8997. 2012
  • New PARP gene with an anti-alphavirus function.  86:8147-8160. 2012
  • Antibody-dependent cellular cytotoxicity against primary hivinfected CD4 + T cells is directly associated with the magnitude of surface igg binding.  86:8672-8680. 2012
  • Evasion of the innate immune response: The old world alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II.  86:7180-7191. 2012
  • Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate.  86:7256-7267. 2012
  • Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.  86:6835-6846. 2012
  • Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets.  86:7118-7125. 2012
  • Early events in alphavirus replication determine the outcome of infection.  86:5055-5066. 2012
  • Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12.  86:5304-5313. 2012
  • Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.  86:4548-4558. 2012
  • Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.  86:4234-4244. 2012
  • Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.  86:2715-2728. 2012
  • Evolutionary dynamics of local pandemic H1N1/2009 influenza virus lineages revealed by whole-genome analysis.  86:11-18. 2012
  • Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: Possible involvement in the pathogenesis of human H5N1 virus infection.  86:667-678. 2012
  • Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection.  85:11196-11207. 2011
  • Ocular tropism of influenza a viruses: Identification of H7 subtype-specific host responses in human respiratory and ocular cells.  85:10117-10125. 2011
  • Chimeric chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response.  85:9249-9252. 2011
  • Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes.  85:8894-8902. 2011
  • Conservation of a packaging signal and the viral genome RNA packaging mechanism in alphavirus evolution..  85:8022-8036. 2011
  • Construction of a full transcription map of human papillomavirus type 18 during productive viral infection..  85:8080-8092. 2011
  • An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum.  85:7029-7036. 2011
  • Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein.  85:5546-5554. 2011
  • A role for the small GTPase Rab6 in assembly of human cytomegalovirus.  85:5213-5219. 2011
  • Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype.  85:4363-4376. 2011
  • Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.  85:5027-5035. 2011
  • Access to RNA encapsidated in the nucleocapsid of vesicular stomatitis virus.  85:2714-2722. 2011
  • Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers.  85:2316-2324. 2011
  • The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells (Journal of Virology (2005) 79, 4, (2261-2273)).  85:3041. 2011
  • Viral exploitation of host SOCS protein functions.  85:1912-1921. 2011
  • Pathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic.  85:1563-1572. 2011
  • Conservation of a packaging signal and the Vira genome RNA packaging mechanism in alphavirus evolution.  85:8022-8036. 2011
  • Construction of a full transcription map of human papillomavirus type 18 during productive viral infection.  85:8080-8092. 2011
  • Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: Kinetics from epithelial cell culture and computational modeling.  85:1125-1135. 2011
  • The 2009 pandemic H1N1 and triple-reassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells.  85:686-696. 2011
  • Immature and transitional B cells are latency reservoirs for a gammaherpesvirus..  84:13045-13052. 2010
  • NFAT and CREB regulate Kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2)..  84:12733-12753. 2010
  • Vaccinia virus D4 mutants defective in processive DNA synthesis retain binding to A20 and DNA.  84:12325-12335. 2010
  • Functional sindbis virus replicative complexes are formed at the plasma membrane.  84:11679-11695. 2010
  • The C-terminal α-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus.  84:11532-11541. 2010
  • Crystallographic structure of porcine adenovirus type 4 fiber head and galectin domains.  84:10558-10568. 2010
  • Hit-and-run stimulation: A novel concept to reactivate latent HIV-1 infection without cytokine gene induction.  84:8712-8720. 2010
  • Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection.  84:7613-7624. 2010
  • Use of a virus-encoded enzymatic marker reveals that a stable fraction of memory B cells expresses latency-associated nuclear antigen throughout chronic gammaherpesvirus infection..  84:7523-7534. 2010
  • Optimal replication of human cytomegalovirus correlates with endocytosis of glycoprotein gpUL132.  84:7039-7052. 2010
  • Wide variation in the multiplicity of HIV-1 infection among injection drug users.  84:6241-6247. 2010
  • Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles (Journal of Virology (2009) 83, 24 (12680-12691)).  84:4864. 2010
  • Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.  84:4194-4203. 2010
  • Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination.  84:4998-5006. 2010
  • Venezuelan equine encephalitis virus capsid protein forms a tetrameric complex with CRM1 and importin α/β that obstructs nuclear pore complex function.  84:4158-4171. 2010
  • Bicaudal D1-dependent trafficking of human cytomegalovirus tegument protein pp150 in virus-infected cells.  84:3162-3177. 2010
  • Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.  84:2610-2617. 2010
  • Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas.  84:1464-1476. 2010
  • Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein.  84:10004-10015. 2010
  • Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix.  84:503-515. 2010
  • Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles.  83:12680-12691. 2009
  • Targeted transduction via CD4 by a lentiviral vector uses a clathrin-mediated entry pathway.  83:13026-13031. 2009
  • Characterization of a mumps virus nucleocapsidlike particle.  83:11402-11406. 2009
  • Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human t cells.  83:11283-11297. 2009
  • Structural and functional elements of the promoter encoded by the 5′ untranslated region of the Venezuelan equine encephalitis virus genome.  83:8327-8339. 2009
  • Random insertion mutagenesis of sindbis virus nonstructural protein 2 and selection of variants incapable of downregulating cellular transcription.  83:9031-9044. 2009
  • Reassortment between avian H5N1 and human H3N2 influenza viruses in ferrets: A public health risk assessment.  83:8131-8140. 2009
  • Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters.  83:8182-8190. 2009
  • Ocular infection of mice with influenza A (H7) viruses: A site of primary replication and spread to the respiratory tract.  83:7075-7084. 2009
  • Early control of H5N1 influenza virus replication by the type I interferon response in mice.  83:5825-5834. 2009
  • Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.  83:5726-5734. 2009
  • Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency.  83:3078-3093. 2009
  • Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection.  83:3258-3267. 2009
  • Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: Antiviral potential of exogenous alpha interferon to reduce virus shedding.  83:2851-2861. 2009
  • Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma.  83:1240-1259. 2009
  • Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice.  82:12172-12180. 2008
  • Structural determinant of human La protein critical for internal initiation of translation of hepatitis C virus RNA..  82:11927-11938. 2008
  • Different types of nsP3-containing protein complexes in sindbis virus-infected cells.  82:10088-10101. 2008
  • The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype.  82:10271-10278. 2008
  • Analysis of natural sequence variation and covariation in human immunodeficiency virus type 1 integrase.  82:9228-9235. 2008
  • A new role for ns polyprotein cleavage in Sindbis virus replication.  82:6218-6231. 2008
  • Identification of mutated cyclization sequences that permit efficient replication of West Nile virus genomes: Use in safer propagation of a novel vaccine candidate.  82:6942-6951. 2008
  • Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration.  82:6458-6469. 2008
  • Multimerization of tegument protein pp28 within the assembly compartment is required for cytoplasmic envelopment of human cytomegalovirus.  82:6272-6287. 2008
  • Human immunodeficiency virus type 1 Vpr binds to the N lobe of the Wee1 kinase domain and enhances kinase activity for Cdc2.  82:5672-5682. 2008
  • Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.  82:4862-4873. 2008
  • Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes.  82:5054-5067. 2008
  • Infectivity studies of influenza virus hemagglutinin receptor binding site mutants in mice.  82:5079-5083. 2008
  • Structural and nonstructural protein genome regions of eastern equine encephalitis virus are determinants of interferon sensitivity and murine virulence.  82:4920-4930. 2008
  • Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection.  82:3295-3310. 2008
  • Venezuelan equine encephalitis virus capsid protein inhibits nuclear import in mammalian but not in mosquito cells.  82:4028-4041. 2008
  • Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted gag epitope in chronic human immunodeficiency virus type 1 infection (Journal of Virology (2007) 81, 15, (8346-8351)).  82:3161. 2008
  • Role of intermolecular interactions of vesicular stomatitis virus nucleoprotein in RNA encapsidation.  82:674-682. 2008
  • Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription.  81:13552-13565. 2007
  • Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture.  81:13783-13793. 2007
  • Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.  81:12608-12618. 2007
  • Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape.  81:11982-11991. 2007
  • Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells.  81:12439-12449. 2007
  • Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines.  81:12071-12076. 2007
  • Nuclear export of the human cytomegalovirus tegument protein pp65 requires cyclin-dependent kinase activity and the Crm1 exporter.  81:11730-11736. 2007
  • Production of pseudoinfectious yellow fever virus with a two-component genome.  81:11737-11748. 2007
  • Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus.  81:11722-11729. 2007
  • Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.  81:10869-10878. 2007
  • Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: Enhanced virulence of eurasian H7N7 viruses isolated from humans.  81:11139-11147. 2007
  • The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses.  81:10818-10821. 2007
  • The cytoplasmic tail of glycoprotein M (gpUL100) expresses trafficking signals required for human cytomegalovirus assembly and replication.  81:10316-10328. 2007
  • Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire.  81:9331-9338. 2007
  • Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted gag epitope in chronic human immunodeficiency virus type 1 infection.  81:8346-8351. 2007
  • Dynein-dependent transport of the Hantaan virus nucleocapsid protein to the endoplasmic reticulum-Golgi intermediate compartment.  81:8634-8647. 2007
  • Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.  81:7238-7248. 2007
  • Cytoplasmic envelopment of human cytomegalovirus requires the postlocalization function of tegument protein pp28 within the assembly compartment.  81:6536-6547. 2007
  • Human serum amyloid A protein inhibits hepatitis C virus entry into cells.  81:6128-6133. 2007
  • Development of Sindbis viruses encoding nsP2/GFP chimeric proteins and their application for studying nsP2 functioning.  81:5046-5057. 2007
  • Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import.  81:5066-5078. 2007
  • Novel nuclear import of Vpr promoted by importin a is crucial for human immunodeficiency virus type 1 replication in macrophages.  81:5284-5293. 2007
  • The carboxy-terminal domain of glycoprotein N of human cytomegalovirus is required for virion morphogenesis.  81:5212-5224. 2007
  • Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: Implications for clinical efficacy.  81:3272-3284. 2007
  • Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.  81:4348-4356. 2007
  • Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice.  81:2736-2744. 2007
  • The old world and new world alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.  81:2472-2484. 2007
  • Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes.  81:1619-1631. 2007
  • Notch1 augments intracellular trafficking of adeno-associated virus type 2.  81:2069-2073. 2007
  • Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions.  81:1043-1047. 2007
  • The unique C termini of orthopoxvirus gamma interferon binding proteins are essential for ligand binding.  80:10675-10682. 2006
  • Complementation of human immunodeficiency virus type 1 replication by intracellular selection of Escherichia coli tRNA3Lys supplied in trans.  80:9641-9650. 2006
  • Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.  80:8469-8481. 2006
  • Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.  80:8909-8919. 2006
  • Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus Ankara enhances antiviral cellular and humoral immune responses.  80:7676-7687. 2006
  • Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: Protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities.  80:7364-7374. 2006
  • Serial passage through human glioma xenografts selects for a Δγ134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors.  80:7308-7315. 2006
  • Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.  80:6517-6524. 2006
  • Cyclin-dependent kinase activity is required for efficient expression and posttranslational modification of human cytomegalovirus proteins and for production of extracellular particles.  80:5886-5896. 2006
  • Human cytomegalovirus attenuates interleukin-1β and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-κB activation.  80:5588-5598. 2006
  • Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans.  80:6056-6060. 2006
  • Sequence requirements for localization of human cytomegalovirus tegument protein pp28 to the virus assembly compartment and for assembly of infectious virus.  80:5611-5626. 2006
  • Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription.  80:5686-5696. 2006
  • Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus.  80:4792-4800. 2006
  • Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response.  80:4591-4600. 2006
  • Formation of nsP3-specific protein complexes during Sindbis virus replication.  80:4122-4134. 2006
  • Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.  80:3732-3742. 2006
  • Crystal structure of the oligomerization domain of the phosphoprotein of vesicular stomatitis virus.  80:2808-2814. 2006
  • Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: Effects of highly active antiretroviral therapy provide insights into the mechanisms of naïve T-cell depletion.  80:2665-2674. 2006
  • Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.  80:2784-2796. 2006
  • Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.  80:1959-1964. 2006
  • Human cytomegalovirus UL97 kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis.  79:15494-15502. 2005
  • Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.  79:14933-14944. 2005
  • Herpes simplex virus type 1 glycoprotein E is required for axonal localization of capsid, tegument, and membrane glycoproteins.  79:13362-13372. 2005
  • Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.  79:13963-13973. 2005
  • Rapid recruitment of virus-specific CD8 T cells restructures immunodominance during protective secondary responses.  79:12703-12713. 2005
  • Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals.  79:11788-11800. 2005
  • Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblasts.  79:11837-11847. 2005
  • Mutagenesis analysis of the rGTP-specific binding site of hepatitis C virus RNA-dependent RNA polymerase.  79:11607-11617. 2005
  • Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.  79:10108-10125. 2005
  • Inhibition of transcription and translation in Sindbis virus-infected cells.  79:9397-9409. 2005
  • Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase.  79:8687-8697. 2005
  • Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in mammalian cells.  79:7597-7608. 2005
  • Structural elements of the tRNA TψC loop critical for nucleocytoplasmic transport are important for human immunodeficiency virus type 1 primer selection.  79:6532-6539. 2005
  • Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.  79:4066-4079. 2005
  • Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts.  79:4043-4054. 2005
  • Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001.  79:4201-4212. 2005
  • Characterization of highly pathogenic H5N1 avian influenza a viruses isolated from South Korea.  79:3692-3702. 2005
  • Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication.  79:3231-3242. 2005
  • Importin-α promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr.  79:3557-3564. 2005
  • Complex formation by glycoproteins M and N of human cytomegalovirus: Structural and functional aspects.  79:2160-2170. 2005
  • The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells.  79:2261-2273. 2005
  • Productive replication of human adenovirus type 5 in canine cells.  79:1308-1311. 2005
  • Sindbis virus with a tricomponent genome.  79:637-643. 2005
  • Three-dimensional localization of the smallest capsid protein in the human cytomegalovirus capsid.  79:1327-1332. 2005
  • Cyclin/CDK regulates the nucleocytoplasmic localization of the human papillomavirus E1 DNA helicase.  78:13954-13965. 2004
  • Definition of sequence requirements for latency-associated nuclear antigen 1 binding to Kaposi's sarcoma-associated herpesvirus DNA.  78:14033-14038. 2004
  • Erratum: Identification of proteins in human cytomegalovirus (HCMV) particles: The HCMV proteome (Journal of Virology (2004) 78:20 (10960-10966)).  78:13395. 2004
  • Evidence and consequence of porcine endogenous retrovirus recombination.  78:13880-13890. 2004
  • Experimental infection of NOD/SCID mice reconstituted with human CD34 + cells with Epstein-Barr virus.  78:13891-13900. 2004
  • Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies.  78:14003-14011. 2004
  • Clonal selection for transcriptionally active viral oncogenes during progression to cancer.  78:11172-11186. 2004
  • Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production.  78:11219-11232. 2004
  • Identification of proteins in human cytomegalovirus (HCMV) particles: The HCMV proteome.  78:10960-10966. 2004
  • Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system.  78:9041-9050. 2004
  • Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway.  78:8573-8581. 2004
  • Increased levels of Wee-1 kinase in G2 are necessary for Vpr- and gamma irradiation-induced G2 arrest.  78:8183-8190. 2004
  • PKR-dependent and -independent mechanisms are involved in translational shutoff during sindbis virus infection.  78:8455-8467. 2004
  • An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.  78:7217-7226. 2004
  • Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.  78:7089-7096. 2004
  • Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.  78:6595-6609. 2004
  • Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus.  78:6688-6691. 2004
  • An Early Stage of Mason-Pfizer Monkey Virus Budding Is Regulated by the Hydrophobicity of the Gag Matrix Domain Core.  78:5023-5031. 2004
  • Changes of the Secondary Structure of the 5′ End of the Sindbis Virus Genome Inhibit Virus Growth in Mosquito Cells and Lead to Accumulation of Adaptive Mutations.  78:4953-4964. 2004
  • Roles of Target Cells and Virus-Specific Cellular Immunity in Primary Simian Immunodeficiency Virus Infection.  78:4866-4875. 2004
  • Effects of Mutations of the Initiation Nucleotides on Hepatitis C Virus RNA Replication in the Cell.  78:3633-3643. 2004
  • Impact of Human Cytomegalovirus Latent Infection on Myeloid Progenitor Cell Gene Expression.  78:4054-4062. 2004
  • Recombinant Modified Vaccinia Virus Ankara Expressing A Soluble Form of Glycoprotein B Causes Durable Immunity and Neutralizing Antibodies against Multiple Strains of Human Cytomegalovirus.  78:3965-3976. 2004
  • Analysis of the 3′ cis-Acting Elements of Rubella Virus by Using Replicons Expressing A Puromycin Resistance Gene.  78:2553-2561. 2004
  • Uncleaved NS2-3 Is Required for Production of Infectious Bovine Viral Diarrhea Virus.  78:2414-2425. 2004
  • Small Internal Deletions in the Human Cytomegalovirus IE2 Gene Result in Nonviable Recombinant Viruses with Differential Defects in Viral Gene Expression.  78:1817-1830. 2004
  • Phosphorylation of Human Cytomegalovirus Glycoprotein B (gB) at the Acidic Cluster Casein Kinase 2 Site (Ser900) Is Required for Localization of gB to the trans-Golgi Network and Efficient Virus Replication.  78:285-293. 2004
  • Rapid Genetic Engineering of Human Cytomegalovirus by Using a Lambda Phage Linear Recombination System: Demonstration that pp28 (UL99) Is Essential for Production of Infectious Virus.  78:539-543. 2004
  • Selection of Functional 5′ cis-Acting Elements Promoting Efficient Sindbis Virus Genome Replication.  78:61-75. 2004
  • The Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 N Terminus Is Essential for Chromosome Association, DNA Replication, and Episome Persistence.  78:294-301. 2004
  • Mechanisms Governing Maintenance of Cdk1/Cyclin B1 Kinase Activity in Cells Infected with Human Cytomegalovirus.  77:13214-13224. 2003
  • Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): Naturally selected mutations in IN augment DNA synthesis.  77:11050-11059. 2003
  • mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.  77:10213-10226. 2003
  • Recombinant Sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.  77:9278-9286. 2003
  • Probing the importance of tRNA anticodon: Human immunodeficiency virus type 1 (HIV-1) RNA genome complementarity with an HIV-1 that selects tRNAGlu for replication.  77:8756-8764. 2003
  • Selection of retroviral reverse transcription primer is coordinated with tRNA biogenesis.  77:8695-8701. 2003
  • Delivery of adeno-associated virus vectors to the fetal retina: Impact of viral capsid proteins on retinal neuronal progenitor transduction.  77:7957-7963. 2003
  • Erratum: Envelopment of human cytomegalovirus occurs by budding into golgi-derived vacuole compartments positive for gB, Rab 3, trans-golgi network 46, and mannosidase II (Journal of Virology (2003) 77:5 (3191-3203)).  77:8179. 2003
  • Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytes.  77:6533-6540. 2003
  • Envelopment of human cytomegalovirus occurs by budding into Golgi-derived vacuole compartments positive for gB, Rab 3, trans-Golgi network 46, and mannosidase II.  77:3191-3203. 2003
  • Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy.  77:3229-3237. 2003
  • Role of the 5′-proximal stem-loop structure of the 5′ untranslated region in replication and translation of hepatitis C virus RNA.  77:3312-3318. 2003
  • Foamy virus envelope glycoprotein is sufficient for particle budding and release.  77:2338-2348. 2003
  • Human cytomegalovirus infection leads to accumulation of geminin and inhibition of the licensing of cellular DNA replication.  77:2369-2376. 2003
  • The interaction between the major capsid protein and the smallest capsid protein of human cytomegalovirus is dependent on two linear sequences in the smallest capsid protein.  77:2730-2735. 2003
  • Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or production.  76:12023-12031. 2002
  • Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands.  76:12900-12907. 2002
  • A P22 scaffold protein mutation increases the robustness of head assembly in the presence of excess portal protein.  76:10245-10255. 2002
  • Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency.  76:8776-8786. 2002
  • Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome.  76:8347-8359. 2002
  • Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1.  76:8276-8284. 2002
  • Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: Pathogenesis.  76:7661-7671. 2002
  • Human immunodeficiency virus-specific CD8+ T cells in human breast milk.  76:7365-7373. 2002
  • Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.  76:7518-7527. 2002
  • Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro.  76:6900-6908. 2002
  • Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver.  76:5692-5700. 2002
  • Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome.  76:5369-5379. 2002
  • Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus.  76:4764-4772. 2002
  • Pathogenesis of avian influenza A (H5N1) viruses in ferrets.  76:4420-4429. 2002
  • The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.  76:4331-4340. 2002
  • Recombinant vaccinia virus-induced T-cell immunity: Quantitation of the response to the virus vector and the foreign epitope.  76:3329-3337. 2002
  • Alternative fates of keratinocytes transduced by human papillomavirus type 18 E7 during squamous differentiation.  76:2964-2972. 2002
  • Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication.  76:2973-2989. 2002
  • Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication..  76:2973-2989. 2002
  • Magnitude of functional CD8+ T-cell responses to the Gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma.  76:2298-2305. 2002
  • ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.  76:292-302. 2002
  • Cervicovaginal lamina propria lymphocytes: Phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251.  76:9-18. 2002
  • Distribution of chemokine receptor ccr2 and ccr5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.  76:662-672. 2002
  • Identification of glycoprotein gpTRL10 as a structural component of human cytomegalovirus.  76:1450-1460. 2002
  • Roles of nonstructural protein nsP2 and alpha/beta interferons in determining the outcome of Sindbis virus infection.  76:11254-11264. 2002
  • Impairment of Gag-specific CD8+ T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.  75:11483-11495. 2001
  • Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells.  75:11365-11372. 2001
  • Palmitoylation of the Rous sarcoma virus transmembrane glycoprotein is required for protein stability and virus infectivity.  75:11544-11554. 2001
  • Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines.  75:11474-11482. 2001
  • Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.  75:10746-10754. 2001
  • Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: Implications for ex vivo immunotherapy.  75:9493-9501. 2001
  • Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.  75:8681-8689. 2001
  • Human papillomavirus E6E7-mediated adenovirus cell killing: Selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes.  75:7602-7611. 2001
  • p21cip1 degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7.  75:6121-6134. 2001
  • In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb.  75:5099-5107. 2001
  • Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza a H5N1 virus infection.  75:5141-5150. 2001
  • Efficient translation initiation is required for replication of bovine viral diarrhea virus subgenomic replicons.  75:4226-4238. 2001
  • Identification of critical elements in the tRNA acceptor stem and TψC loop necessary for human immunodeficiency virus type 1 infectivity.  75:4902-4906. 2001
  • Immunity to influenza A H9N2 viruses induced by infection and vaccination.  75:4896-4901. 2001
  • Herpes simplex virus-induced keratitis: Evaluation of the role of molecular mimicry in lesion pathogenesis.  75:3077-3088. 2001
  • Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.  75:3250-3258. 2001
  • Dissemination and pathology of simian immunodeficiency virus PBj14 early after rectal infection of pig-tailed macaques.  75:278-91. 2001
  • Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).  74:11881-11892. 2000
  • Infection of human dendritic cells by a Sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein.  74:11849-11857. 2000
  • Molecular correlates of influenza A H5N1 virus pathogenesis in mice.  74:10807-10810. 2000
  • Inherent instability of poliovirus genomes containing two internal ribosome entry site (IRES) elements supports a role for the IRES in encapsidation.  74:8335-8342. 2000
  • Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.  74:8358-8367. 2000
  • Two putative α-helical domains of human immunodeficiency virus type 1 Vpr mediate nuclear localization by at least two mechanisms.  74:7179-7186. 2000
  • A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G1 cell cycle arrest.  74:6058-6067. 2000
  • Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans.  74:6105-6116. 2000
  • Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.  74:5495-5501. 2000
  • Protective immunity to rotavirus shedding in the absence of interleukin- 6: Th1 cells and immunoglobulin A develop normally.  74:5250-5256. 2000
  • Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-Golgi-intermediate compartment.  74:3842-3851. 2000
  • Identification of additional coat-scaffolding interactions in a bacteriophage P22 mutant defective in maturation.  74:3871-3873. 2000
  • The hinge of the human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association.  74:3761-3770. 2000
  • Characterization of the R572T point mutant of a putative cleavage site in human foamy virus env.  74:2949-2954. 2000
  • Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: Characterization of a potential site of virus assembly.  74:975-986. 2000
  • De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus.  74:851-863. 2000
  • A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon.  74:10249-10255. 2000
  • Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 Tat in astrocytes.  74:9214-9221. 2000
  • Study of the assembly of vesicular stomatitis virus N protein: Role of the P protein.  74:9515-9524. 2000
  • A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans.  73:5903-5911. 1999
  • An endoplasmic reticulum retrieval signal partitions human foamy virus maturation to intracytoplasmic membranes.  73:7210-7217. 1999
  • Genetic analysis of a unique human immunodeficiency virus type 1 (HIV- 1) with a primer binding site complementary to tRNA(Met) supports a role for U5-PBS stem-loop RNA structures in initiation of HIV-1 reverse transcription.  73:1818-1827. 1999
  • Human cytomegalovirus infection of Caco-2 cells occurs at the basolateral membrane and is differentiation state dependent.  73:4552-4560. 1999
  • Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex.  73:2126-2135. 1999
  • Human papillomavirus DNA replication compartments in a transient DNA replication system.  73:1001-1009. 1999
  • Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells.  73:3854-3865. 1999
  • Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1.  73:8831-8836. 1999
  • Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes.  73:5026-5033. 1999
  • pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion.  73:1785-1794. 1999
  • Adeno-associated virus type 2-mediated gene transfer: Correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein transgene expression in human cells in vitro and murine tissues in vivo.  72:1593-1599. 1998
  • Adeno-associated virus type 2-mediated gene transfer: Role of epidermal growth factor receptor protein tyrosine kinase in transgene expression.  72:9835-9843. 1998
  • An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor- independent cell entry mechanism.  72:9706-9713. 1998
  • Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.  72:2483-2490. 1998
  • Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob.  72:1844-1852. 1998
  • Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.  72:5472-5480. 1998
  • Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.  72:1552-1576. 1998
  • Influenza virus-infected epithelial cells present viral antigens to antigen-specific CD8+ cytotoxic T lymphocytes.  72:4534-4536. 1998
  • Localization of human cytomegalovirus structural proteins to the nuclear matrix of infected human fibroblasts.  72:3321-3329. 1998
  • Membrane organization of bluetongue virus nonstructural glycoprotein NS3.  72:3362-3369. 1998
  • Preferential completion of human immunodeficiency virus type 1 proviruses initiated with tRNA3/(Lys) rather than tRNA1,2/(Lys).  72:5464-5471. 1998
  • Recombinant human parvovirus B19 vectors: Erythroid cell-specific delivery and expression of transduced genes.  72:5224-5230. 1998
  • Retrovital recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation.  72:1195-1202. 1998
  • The carboxyl-terminal region of the human papillomavirus type 16 E1 protein determines E2 protein specificity during DNA replication.  72:3436-3441. 1998
  • Transcription factor YY1 represses cell-free replication from human papillomavirus origins.  72:4911-4917. 1998
  • Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytes.  72:749-757. 1998
  • A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1.  71:5885-5893. 1997
  • A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum.  71:778-784. 1997
  • Adeno-associated virus type 2 DNA replication in vivo: Mutation analyses of the D sequence in viral inverted terminal repeats.  71:3077-3082. 1997
  • Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation.  71:8262-8267. 1997
  • Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo.  71:3098-3104. 1997
  • Encapsidation of adeno-associated virus type 2 rep proteins in wild- type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells.  71:7361-7371. 1997
  • Glycoprotein H-related complexes of human cytomegalovirus: Identification of a third protein in the gCIII complex.  71:3090-3097. 1997
  • Homologous recombination occurs in a distinct retroviral subpopulation and exhibits high negative interference.  71:6028-6036. 1997
  • Identification of a Sequence within U5 Required for Human Immunodeficiency Virus Type 1 to Stably Maintain a Primer Binding Site Complementary to tRNAMet.  71:207-217. 1997
  • Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.  71:7704-7710. 1997
  • Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus.  71:4062-4070. 1997
  • Nucleotide substitutions within U5 are critical for efficient reverse transcription of human immunodeficiency virus type 1 with a primer binding site complementary to tRNA.  71:6315-6322. 1997
  • Packaging Signals in Alohaviruses.  71:248-258. 1997
  • Role of sialyloligosaccharide binding in Theiler's virus persistence.  71:9701-9712. 1997
  • Sindbis virus replicons and sindbis virus: Assembly of chimeras and of particles deficient in virus RNA.  71:2819-2829. 1997
  • Transcription activities of human papillomavirus type 11 E6 promoter- proximal elements in raft and submerged cultures of foreskin keratinocytes.  71:8832-8840. 1997
  • Virus-specific, CD8+ major histocompatibility complex class I- restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus- infected β2-microglobulin-deficient mice.  71:8392-8396. 1997
  • A novel mechanism for persistence of human cytomegalovirus in macrophages.  70:1855-1862. 1996
  • Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus.  70:4246-4252. 1996
  • Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNAHis.  70:966-971. 1996
  • Efficient initiation and strand transfer of polypurine tract-primed plus-strand DNA prevent strand transfer of internally initiated plus-strand DNAs.  70:1687-1694. 1996
  • Endogenous reverse transcription assays reveal high-level resistance to the triphosphate of (-)2'-dideoxy-3'-thiacytidine by mutated M184V human immunodeficiency virus type 1.  70:5642-5645. 1996
  • Human cytomegalovirus (HCMV) smallest capsid protein identified as product of short open reading frame located between HCMV UL48 and UL49.  70:5680-5683. 1996
  • Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.  70:3378-3384. 1996
  • Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 gag.  70:2643-2649. 1996
  • Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: Selective encapsidation of viral genomes in progeny virions.  70:1668-1677. 1996
  • Translation of Sindbis virus mRNA: Analysis of sequences downstream of the initiating AUG codon that enhance translation.  70:1182-1190. 1996
  • Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.  69:1540-1547. 1995
  • An aspartic acid at amino acid 108 is required to rescue infectious virus after transfection of a poliovirus cDNA containing a CGDD but not SGDD amino acid motif in 3D(pol).  69:8173-8177. 1995
  • Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase.  69:1359-1366. 1995
  • Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.  69:1548-1555. 1995
  • Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages.  69:3737-3743. 1995
  • Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H.  69:6047-6053. 1995
  • Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA3/(Lys).  69:6021-6029. 1995
  • In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease.  69:5228-5235. 1995
  • Mutation of the aspartic acid residues of the GDD sequence motif of poliovirus RNA-dependent RNA polymerase results in enzymes with altered metal ion requirements for activity.  69:1532-1539. 1995
  • Postoligomerization folding of human cytomegalovirus glycoprotein B: Identification of folding intermediates and importance of disulfide bonding.  69:7015-7022. 1995
  • Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.  69:3389-3398. 1995
  • The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.  69:7630-7638. 1995
  • Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2.  69:8096-8101. 1995
  • Analysis of the primary T-cell response to Sendai virus infection in C57BL/6 mice: CD4+ T-cell recognition is directed predominantly to the hemagglutinin-neuraminidase glycoprotein.  68:6863-6870. 1994
  • Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells.  68:1721-1727. 1994
  • Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.  68:1115-1127. 1994
  • In vitro characterization of an internal ribosomal entry site (IRES) present within the 5' nontranslated region of hepatitis A virus RNA: Comparison with the IRES of encephalomyocarditis virus.  68:1066-1074. 1994
  • Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.  68:6161-6169. 1994
  • Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.  68:1605-1614. 1994
  • Mutations at palmitylation sites of the influenza virus hemagglutinin affect virus formation.  68:5748-5754. 1994
  • Translation of sindbis virus mRNA: Effects of sequences downstream of the initiating codon.  68:8111-8117. 1994
  • A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells.  67:4621-4629. 1993
  • Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.  67:3684-3690. 1993
  • Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 gag and pol proteins upon infection.  67:3712-3719. 1993
  • Enzymatic activity of poliovirus RNA polymerases with mutations at the tyrosine residue of the conserved YGDD motif: Isolation and characterization of polioviruses containing RNA polymerases with FGDD and MGDD sequences.  67:373-381. 1993
  • Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites.  67:489-496. 1993
  • Poliovirus capsid proteins derived from P1 precursors with glutamine- valine cleavage sites have defects in assembly and RNA encapsidation.  67:7284-7297. 1993
  • Regulation of the human papillomavirus type 11 E6 promoter by viral and host transcription factors in primary human keratinocytes.  67:1721-1726. 1993
  • Sindbis virus expression vectors: Packaging of RNA replicons by using defective helper RNAs.  67:6439-6446. 1993
  • A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.  66:5290-5297. 1992
  • Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins.  66:5224-5231. 1992
  • Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts.  66:1129-1138. 1992
  • In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome.  66:6806-6812. 1992
  • Mechanism of attenuation of a chimeric influenza A/B transfectant virus.  66:4679-4685. 1992
  • Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.  66:4556-4563. 1992
  • Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).  66:6747-6754. 1992
  • The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.  66:1303-1311. 1992
  • The nonmyristylated Pr160(gag-pol) polyprotein of human immunodeficiency virus type 1 interacts with Pr55(gag) and is incorporated into viruslike particles.  66:6304-6313. 1992
  • An E1M--E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor..  65:3317-3329. 1991
  • An E1M E2C fusion protein encoded by human papillomavirus type 11 is a sequence-specific transcription repressor.  65:3317-3329. 1991
  • Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures.  65:2088-2092. 1991
  • Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription.  65:4555-4564. 1991
  • Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus.  65:138-146. 1991
  • Enzymatic activity of poliovirus RNA polymerase mutants with single amino acid changes in the conserved YGDD amino acid motif.  65:4565-4572. 1991
  • Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons.  65:2875-2883. 1991
  • Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes.  65:3973-3985. 1991
  • Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production.  65:5111-5117. 1991
  • The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure.  65:2861-2867. 1991
  • A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses.  64:6176-6183. 1990
  • A specific base transition occurs on replicating hepatitis delta virus RNA.  64:1021-1027. 1990
  • Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): Use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response.  64:1079-1085. 1990
  • Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus.  64:1808-1811. 1990
  • Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts.  64:3144-3149. 1990
  • Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice.  64:3310-3318. 1990
  • Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.  64:890-901. 1990
  • Relative accessibility of N-acetylglucosamine in trimers of the adenovirus types 2 and 5 fiber proteins.  64:5317-5323. 1990
  • Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne.  64:2922-2931. 1990
  • Specificities involved in the initiation of retroviral plus-strand DNA.  64:592-597. 1990
  • Template switching by reverse transcriptase during DNA synthesis.  64:4321-4328. 1990
  • Evidence for interference, coinfections, and intertypic virus enhancement of infection by ovine-caprine lentiviruses.  63:4682-4688. 1989
  • Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.  63:1995-2001. 1989
  • Identification of a novel constitutive enhancer element and an associated binding protein: Implications for human papillomatovirus type 11 enhancer regulation.  63:2967-2976. 1989
  • Modulation of lentivirus replication by antibodies: Fc portion of immunoglobulin molecule is essential for enhancement of binding internalization, and neutralization of visna virus in macrophages.  63:1811-1813. 1989
  • Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.  63:403-410. 1989
  • Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIV(MAC).  62:3501-3505. 1988
  • Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB).  62:3309-3318. 1988
  • Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: Functional and biochemical studies.  62:2994-3002. 1988
  • The putative trans-activator in the MA(gag) region of Rous sarcoma virus is not required for cell transformation.  62:4767-4769. 1988
  • Enhancers and trans-acting E2 transcriptional factors of papillomaviruses.  61:2599-2606. 1987
  • Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata.  61:2581-2588. 1987
  • Identification and mapping of human papillomavirus type 1 RNA transcripts recovered from plantar warts and infected epithelial cell cultures.  61:1913-1918. 1987
  • Human cytomegalovirus virion-associated protein with kinase activity.  59:185-188. 1986
  • Isolation of mycoplasma virus L2 insertion variants and miniviruses.  59:584-590. 1986
  • Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.  58:185-191. 1986
  • Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus.  56:419-425. 1985
  • Identification of an enveloped phage, mycoplasma virus L172, that contains a 14-kilobase single-stranded DNA genome.  53:384-390. 1985
  • Morphogenesis of bacteriophage phi29 of Bacillus subtilis: Prohead restoration for DNA-gp3 packaging and assembly.  53:858-861. 1985
  • Partial nucleotide sequence of Rous sarcoma virus-29 provides evidence that the original Rous sarcoma virus was replication defective.  55:728-735. 1985
  • Purification of a soluble template-dependent rhinovirus RNA polymerase and its dependence on a host cell protein for viral RNA synthesis.  53:266-272. 1985
  • ATP is required for initiation of poliovirus RNA synthesis in vitro: Demonstration of tyrosine-phosphate linkage between in vitro-synthesized RNA and genome-linked protein.  50:515-523. 1984
  • Bacteriophage φ29 proteins required for in vitro DNA-gp3 packaging.  50:766-772. 1984
  • Amino-terminal amino acid sequence of p10, the fifth major gag polypeptide of avian sarcoma and leukemia viruses.  45:885-888. 1983
  • Antibody to a synthetic nonapeptide corresponding to the NH2 terminus of poliovirus genome-linked protein VPg reacts with native VPg and inhibits in vitro replication of poliovirus RNA.  48:429-439. 1983
  • Morphogenesis of bacteriophage φ29 of Bacillus subtilis: Oriented and quantized in vitro packaging of DNA protein gp3.  45:383-396. 1983
  • Morphogenesis of bacteriophage Φ29 of Bacillus subtilis: DNA-gp3 intermediate in in vivo and in vitro assembly.  41:508-517. 1982
  • Selective dansylation of M protein within intact influenza virions.  44:871-876. 1982
  • Comparison of late mRNA splicing among class B and class C adenoviruses.  30:899-912. 1979
  • Structure of the membrane protein of influenza virus. I. Isolation and characterization of cyanogen bromide cleavage products.  30:759-766. 1979
  • Origin of the minor glycoproteins of murine leukemia viruses.  28:84-94. 1978

    • International Standard Serial Number (issn)

  • 0022-538X

    • Electronic International Standard Serial Number (eissn)

  • 1098-5514